Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
LIMN
#3891
Liminatus Pharma, Inc. Class A Common Stock
0.2
5
+8.70%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+8.70%
Monthly Change
-61.54%
6 month change
-91.67%
Year Change
-97.35%
Previous Close
0.2
3
Open
0.2
5
Bid
Ask
Low
0.2
5
High
0.2
5
Volume
1
Markets
US Stock Market
LIMN
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
26.01 M
27.06 M
27.06 M
—
Valuation ratios
Enterprise value
—
300.43 M
44.47 M
—
Price to earnings ratio
—
—
—
—
Price to sales ratio
—
—
—
—
Price to cash flow ratio
—
—
—
—
Price to book ratio
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
Profitability ratios
Return on assets %
—
0.06
-1.36
—
Return on equity %
0.24
-0.01
1.11
—
Return on invested capital %
—
—
—
—
Gross margin %
—
—
—
—
Operating margin %
—
—
—
—
EBITDA margin %
—
—
—
—
Net margin %
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
Current ratio
—
0.17
0.42
—
Inventory turnover
—
—
—
—
Asset turnover
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
Debt to equity ratio
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
Per share metrics
Operating cash flow per share
0
-0.39
-0.02
—
EBIT per share
—
—
—
—
EBITDA per share
—
—
—
—
Total debt per share
—
—
—
—
Cash per share
—
0.06
0.03
—
Net current asset value per share
—
0.08
0.04
—
Tangible book value per share
-10.6
-0.38
-0.06
—
Working capital per share
—
-0.37
-0.06
—
Book value per share
-10.6
-0.38
-0.06
—